| Tissue | Methodology | PMID |
|---|---|---|
| Testis | Northern blot | 9724777 |
| Prostate | Northern blot | 9724777 |
| Uterus | Northern blot | 9724777 |
| Fallopian tube | Northern blot | 9724777 |
| Placenta | Northern blot | 9724777 |
| Prostate | Dot-blot | 12489849 |
| Cervix | Dot-blot | 12489849 |
Breast cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Breast carcinoma |
0/9 (0%) | Dot-blot | 12489849 |
Gynecological cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Cervical carcinoma |
1/1 (100%) | Dot-blot | 12489849 | |
| Uterine carcinoma |
2/7 (29%) | Dot-blot |
Ovarian cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Ovarian carcinoma |
0/4 (0%) | Dot-blot | 12489849 |
Prostate cancer Show
2005-2009© CT Antigens Database